Company: Fresenius reduces its stake in Fresenius Medical Care
Fresenius reduces its stake in the dialysis provider by almost three percent. The proceeds from the sale of around eight million shares do not all go into more growth.
Fresenius, a German healthcare company, has reduced its stake in dialysis provider Fresenius Medical Care (FMC) by selling 7.8 million shares to institutional investors for approximately 300 million euros. This sale brings Fresenius' stake in FMC down from 27.8% to around 25%. The company plans to use the proceeds to invest in its growth platforms and pay off debt. Fresenius CEO Michael Sen said the move will give the company more flexibility to make targeted investments.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
